근육병 환자의 평가를 위한 임상 척도

키워드

참고문헌 (40)

1. Landon-Cardinal O, "Rituximab in the treatment of refractory anti-HMGCR immune-mediated necrotizing myopathy", J Rheumatol, 46, pp.623~627 (2019)
2. Noss EH, "Rituximab as therapy for refractory polymyositis and dermatomyositis", J Rheumatol, 33, pp.1021~1026 (2006)
3. Mendell JR, "Eteplirsen for the treatment of Duchenne muscular dystrophy", Ann Neurol, 74, pp.637~647 (2013)
4. Frank DE, "Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy", Neurology, 94, pp.e2270~e2282 (2020)
5. Dahl TH, "International classification of functioning, disability and health: an introduction and discussion of its potential impact on rehabilitation services and research", J Rehabil Med, 34, pp.201~204 (2002)
6. Rosenfeld J, "Neuromuscular disorders in clinical practice", pp.316~317 (2002), Butterworth-Heinemann
7. Stein F, "Clinical research in allied health and special education" (1996), Singular Publishing Group
8. Brigadier G, "Aids to the examination of the peripheral nervous system", pp.70~ (1943), Crown Copyright
9. Brooke MH, "Clinical trial in Duchenne dystrophy. I. The design of the protocol", Muscle Nerve, 4, pp.186~197 (1981)
10. Scott O, "Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy", Muscle Nerve, 5, pp.291~301 (1982)
11. Hoogendijk JE, "119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands", Neuromuscul Disord, 14, pp.337~345 (2004)
12. Escolar D, "Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children", Muscle Nerve, 24, pp.787~793 (2001)
13. Merlini L, "Reliability of hand‐held dynamometry in spinal muscular atrophy", Muscle Nerve, 26, pp.64~70 (2002)
14. Stuberg WA, "Reliability of quantitative muscle testing in healthy children and in children with Duchenne muscular dystrophy using a hand-held dynamometer", Phys Ther, 68, pp.977~982 (1988)
15. Bohannon RW, "Intertester reliability of hand-held dynamometry: a concise summary of published research", Percept Mot Skills, 88, pp.899~902 (1999)
16. Bushby K, "Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings", Clin Investig, 1, pp.1217~1235 (2011)
17. MacKenzie CR, "Standards for the use of ordinal scales in clinical trials", Br Med J (Clin Res Ed), 292, pp.40~43 (1986)
18. Vignos PJ, "Management of progressive muscular dystrophy of childhood", JAMA, 184, pp.89~96 (1963)
19. Fanin M, "Muscle pathology in dysferlin deficiency", Neuropathol Appl Neurobiol, 28, pp.461~470 (2002)
20. Mathieu J, "Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy", Neurology, 56, pp.336~340 (2001)
21. Bérard C, "A motor function measure scale for neuromuscular diseases. Construction and validation study", Neuromuscul Disord, 15, pp.463~470 (2005)
22. Mercuri E, "Revised North Star Ambulatory Assessment for young boys with Duchenne muscular dystrophy", PLoS One, 11, pp.e0160195~ (2016)
23. Ramsey D, "Revised Hammersmith Scale for spinal muscular atrophy: a SMA specific clinical outcome assessment tool", PLoS One, 12, pp.e0172346~ (2017)
24. Harris E, "The clinical outcome study for dysferlinopathy: an international multicenter study", Neurol Genet, 2, pp.e89~ (2016)
25. Harris‐Love MO, "Reliability of the adult myopathy assessment tool in individuals with myositis", Arthritis Care Res, 67, pp.563~570 (2015)
26. Jackson C, "Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity", Muscle Nerve, 37, pp.473~476 (2008)
27. Mazzone ES, "Revised upper limb module for spinal muscular atrophy: development of a new module", Muscle Nerve, 55, pp.869~874 (2017)
28. Pane M, "Reliability of the performance of upper limb assessment in Duchenne muscular dystrophy", Neuromuscul Disord, 24, pp.201~206 (2014)
29. Florence JM, "Clinical trials in Duchenne dystrophy: standardization and reliability of evaluation procedures", Phys Ther, 64, pp.41~45 (1984)
30. Mayhew JE, "Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy", Muscle Nerve, 35, pp.36~42 (2007)
31. Beenakker EA, "Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients", Eur J Paediatr Neurol, 9, pp.387~393 (2005)
32. McDonald CM, "The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy", Muscle Nerve, 41, pp.500~510 (2010)
33. Clarke LA, "Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I", Pediatrics, 123, pp.229~240 (2009)
34. Li D, "Assessment of treatment effect with multiple outcomes in 2 clinical trials of patients with Duchenne muscular dystrophy", JAMA Net Open, 3, pp.e1921306~ (2020)
35. Kingsley C, "Patient-reported outcome measures and patient-reported experience measures", Bja Education, 17, pp.137~144 (2017)
36. Brazier JE, "Validating the SF-36 health survey questionnaire: new outcome measure for primary care", BMJ, 305, pp.160~164 (1992)
37. Vincent K, "Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL)", Neurology, 68, pp.1051~1057 (2007)
38. Sansone V, "Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases", Euro J Neurol, 17, pp.1178~1187 (2010)
39. Seesing FM, "The individualized neuromuscular quality of life questionnaire:cultural translation and psychometric validation for the Dutch population", Muscle Nerve, 51, pp.496~500 (2015)
40. Fujino H, "Validation of the individualized neuromuscular quality of life in Japanese patients with myotonic dystrophy", Muscle Nerve, 58, pp.56~63 (2018)

관련 논문AI추천